Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Venetoclax Plus Dose-adjusted EPOCH-R for Richter's Syndrome

Trial Profile

Venetoclax Plus Dose-adjusted EPOCH-R for Richter's Syndrome

Phase of Trial: Phase II

Latest Information Update: 22 Mar 2018

At a glance

  • Drugs Venetoclax (Primary) ; Cyclophosphamide; Doxorubicin; Etoposide; Prednisone; Rituximab; Vincristine
  • Indications Chronic lymphocytic leukaemia; Diffuse large B cell lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Mar 2017 Status changed from not yet recruiting to recruiting.
    • 20 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top